Host Wnt/β-catenin pathway triggered by Helicobacter pylori correlates with regression of gastric intestinal metaplasia after H. pylori eradication

Journal of Medical Microbiology

Volumn 58, Issue 5, 2009, Pages 567-576

  Hung, Kuei Hsiang ^a   Wu, Jiunn Jong ^a   Yang, Hsiao Bai ^a,b   Su, Li Ju ^a   Sheu, Bor Shyang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Ton Yen General Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; GLYCOGEN SYNTHASE KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; UVOMORULIN; WNT PROTEIN;

ADULT; ARTICLE; BACTERIUM ISOLATE; CELL LINE; COLON POLYPOSIS; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; GENOTYPE; HELICOBACTER PYLORI; HOST; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SINGLE NUCLEOTIDE POLYMORPHISM;

BETA CATENIN; CELL LINE; CYCLOOXYGENASE 2; DNA PRIMERS; GASTRIC MUCOSA; GENES, APC; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; INTESTINES; LONGITUDINAL STUDIES; METAPLASIA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 67650447457     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.007310-0     Document Type: Article

References (38)

1. Cheung, T. K., Xia, H. H. & Wong, B. C. (2007). Helicobacter pylori eradication for gastric cancer prevention. J Gastroenterol 42 (Suppl. 17), 10-15. (Pubitemid 46140357)
2. Clevers, H. (2006). Wnt/β-catenin signaling in development and disease. Cell 127, 469-480.
3. Cohen, P. & Frame, S. (2001). The renaissance of GSK3. Nat Rev Mol Cell Biol 2, 769-776.
4. Correa, P. & Houghton, J. (2007). Carcinogenesis of Helicobacter pylori. Gastroenterology 133, 659-672.
5. Correa, P., Fontham, E. T., Bravo, J. C., Bravo, L. E., Ruiz, B., Zarama, G., Realpe, J. L., Malcom, G. T., Li, D. & other authors (2000). Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 92, 1881-1888.
6. Dixon, M. F., Genta, R. M., Yardley, J. H. & Correa, P. (1996). Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20, 1161-1181.
7. Franco, A. T., Israel, D. A., Washington, M. K., Krishna, U., Fox, J. G., Rogers, A. B., Neish, A. S., Collier-Hyams, L., Perez-Perez, G. I. & other authors (2005). Activation of β-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A 102, 10646-10651. (Pubitemid 41061608)
8. Ikenoue, T., Ijichi, H., Kato, N., Kanai, F., Masaki, T., Rengifo, W., Okamoto, M., Matsumura, M., Kawabe, T. & other authors (2002). Analysis of the β-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells. Jpn J Cancer Res 93, 1213-1220.
9. Jeng, Y. M., Wu, M. Z., Mao, T. L., Chang, M. H. & Hsu, H. C. (2000). Somatic mutations of β-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Cancer Lett 152, 45-51. (Pubitemid 30169017)
10. Kurashima, Y., Murata-Kamiya, N., Kikuchi, K., Higashi, H., Azuma, T., Kondo, S. & Hatakeyama, M. (2008). Deregulation of β-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int J Cancer 122, 823-831.
11. Leung, W. K., Lin, S. R., Ching, J. Y., To, K. F., Ng, E. K., Chan, F. K., Lau, J. Y. & Sung, J. J. (2004). Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 53, 1244-1249. (Pubitemid 39120105)
12. Lim, H. Y., Joo, H. J., Choi, J. H., Yi, J. W., Yang, M. S., Cho, D. Y., Kim, H. S., Nam, D. K., Lee, K. B. & Kim, H. C. (2000). Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 6, 519-525. (Pubitemid 30111473)
13. Lu, C. C., Sheu, B. S., Chen, T. W., Yang, H. B., Hung, K. H., Kao, A. W., Chuang, C. H. & Wu, J. J. (2005). Host TNF-α-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection. Am J Gastroenterol 100, 1274-1282. (Pubitemid 40904349)
14. McCarthy, C. J., Crofford, L. J., Greenson, J. & Scheiman, J. M. (1999). Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 94, 1218-1223. (Pubitemid 29214632)
15. Murata-Kamiya, N., Kurashima, Y., Teishikata, Y., Yamahashi, Y., Saito, Y., Higashi, H., Aburatani, H., Akiyama, T., Peek, R. M., Jr & other authors (2007). Helicobacter pylori CagA interacts with Ecadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26, 4617-4626. (Pubitemid 47067401)
16. Nakayama, M., Hisatsune, J., Yamasaki, E., Isomoto, H., Kurazono, H., Hatakeyama, M., Azuma, T., Yamaoka, Y., Yahiro, K. & other authors (2009). Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem 284, 1612-1619.
17. Nathke, I. (2006). Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC. Nat Rev Cancer 6, 967-974. (Pubitemid 44862681)
18. Ogasawara, N., Tsukamoto, T., Mizoshita, T., Inada, K., Cao, X., Takenaka, Y., Joh, T. & Tatematsu, M. (2006). Mutations and nuclear accumulation of β-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology 49, 612-621. (Pubitemid 44924293)
19. Ohkusa, T., Fujiki, K., Takashimizu, I., Kumagai, J., Tanizawa, T., Eishi, Y., Yokoyama, T. & Watanabe, M. (2001). Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 134, 380-386. (Pubitemid 32179477)
20. Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B. & Kinzler, K. (1992). APC mutations occur early during colorectal tumorigenesis. Nature 359, 235-237.
21. Prall, F., Weirich, V. & Ostwald, C. (2007). Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC) gene. Histopathology 50, 318-330. (Pubitemid 46169416)
22. Romiti, A., Zullo, A., Borrini, F., Sarcina, I., Hassan, C., Winn, S., Tomao, S., Vecchione, A., Morini, S. & Mingazzini, P. (2005). Relationship between β-catenin expression and epithelial cell proliferation in gastric mucosa with intestinal metaplasia. World J Gastroenterol 11, 4400-4403. (Pubitemid 41093961)
23. Sheu, B. S., Yang, H. B., Sheu, S. M., Huang, A. H. & Wu, J. J. (2003). Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients. Clin Cancer Res 9, 5245-5251. (Pubitemid 37413575)
24. Sheu, B. S., Odenbreit, S., Hung, K. H., Liu, C. P., Sheu, S. M., Yang, H. B. & Wu, J. J. (2006). Interaction between host gastric sialyl-Lewis X and H. pylori SabA enhances H. pylori density in patients lacking gastric Lewis B antigen. Am J Gastroenterol 101, 36-44. (Pubitemid 43381706)
25. Slattery, M. L., Samowitz, W., Ballard, L., Schaffer, D., Leppert, M. & Potter, J. D. (2001). A molecular variant of the APC gene at codon 1822: its association with diet, lifestyle, and risk of colon cancer. Cancer Res 61, 1000-1004. (Pubitemid 32174417)
26. Sokolova, O., Bozko, P. M. & Naumann, M. (2008). Helicobacter pylori suppresses glycogen synthase kinase 3β to promote β-catenin activity. J Biol Chem 283, 29367-29374.
27. Sung, J. J., Leung, W. K., Go, M. Y., To, K. F., Cheng, A. S., Ng, E. K. & Chan, F. K. (2000a). Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 157, 729-735. (Pubitemid 32109365)
28. Sung, J. J., Lin, S. R., Ching, J. Y., Zhou, L. Y., To, K. F., Wang, R. T., Leung, W. K., Ng, E. K., Lau, J. Y. & other authors (2000b). Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 119, 7-14. (Pubitemid 30452573)
29. Tabassam, F. H., Graham, D. Y. & Yamaoka, Y. (2009). Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3β phosphorylation. Cell Microbiol 11, 70-82.
30. Tajima, Y., Yamazaki, K., Makino, R., Nishino, N., Aoki, S., Kato, M., Morohara, K., Kaetsu, T. & Kusano, M. (2006). Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res 12, 6469-6479. (Pubitemid 44799720)
31. Uemura, N., Mukai, T., Okamoto, S., Yamaguchi, S., Mashiba, H., Taniyama, K., Sasaki, N., Haruma, K., Sumii, K. & Kajiyama, G. (1997). Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6, 639-642. (Pubitemid 27342688)
32. van der Hulst, R. W., van der Ende, A., Dekker, F. W., Ten Kate, F. J., Weel, J. F., Keller, J. J., Kruizinga, S. P., Dankert, J. & Tytgat, G. N. (1997). Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 113, 25-30. (Pubitemid 27281754)
33. Walker, M. M. (2003). Is intestinal metaplasia of the stomach reversible? Gut 52, 1-4.
34. Wei, S. C., Su, Y. N., Tsai-Wu, J. J., Wu, C. H., Huang, Y. L., Sheu, J. C., Wang, C. Y. & Wong, J. M. (2004). Genetic analysis of the APC gene in Taiwanese familial adenomatous polyposis. J Biomed Sci 11, 260-265. (Pubitemid 38269816)
35. Wong, B. C., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H., Yuen, S. T. & other authors (2004). Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291, 187-194. (Pubitemid 38082812)
36. Yang, H. B., Cheng, H. C., Sheu, B. S., Hung, K. H., Liou, M. F. & Wu, J. J. (2007). Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication. Aliment Pharmacol Ther 25, 455-461. (Pubitemid 46184459)
37. Yokozaki, H. (2000). Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int 50, 767-777. (Pubitemid 30943414)
38. Zhang, X., Miao, X., Tan, W., Ning, B., Liu, Z., Hong, Y., Song, W., Guo, Y., Shen, Y. & other authors (2005). Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129, 565-576. (Pubitemid 41096644)